About lino Biotech
lino Biotech is a Healthcare company based in Zurich (Switzerland) founded in 2020 by Andreas Frutiger and Tilman Hoss, and was acquired by Miltenyi Biotec in February 2023. Molecular interactions in biological samples are measured via focal molography. lino Biotech offers products and services including MACS® Matchmaker, Sensor Chips, DNA Adaptors, and Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is lino Biotech AG.
Company details
Focal molography technology was established in 2020 in Zurich, Switzerland, within the biotechnology sector. Photolithography, molecular self-assembly, and optical systems are integrated into a device for label-free assays. Molecular interactions are detected in living cells or unprocessed biological samples. Operations focus on advancing detection methods for research applications.
- Headquarters Zurich, Switzerland
- Founders Andreas Frutiger, Tilman Hoss
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website lino-biotech.com
- Social LinkedIn
- Acquired by Miltenyi Biotec (Feb 2023)
- Legal Name Lino Biotech Ag
- InvestorsRoche
& 2 more
- Acquired byMiltenyi Biotec
(Feb 2023)
Products & Services of lino Biotech
lino Biotech offers a comprehensive portfolio of products and services, including MACS® Matchmaker, Sensor Chips, DNA Adaptors, and Kits.
Platform for quantitative analysis of biomolecular interactions.
Components for measuring interactions in biological matrices.
Tools for DNA-based binder development in research.
Packages for automated biological interaction assays.
Funding Insights of lino Biotech
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of lino Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in lino Biotech
lino Biotech has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, Miltenyi Biotec and High-Tech GrĂĽnderfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | roche.com | Basel, Switzerland | |
Develops tools and products for research and clinical application | 1989 | miltenyibiotec.com | Bergisch Gladbach, Germany |
Investor details for lino Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of lino Biotech
12 people are tracked at lino Biotech (3 in leadership, 7 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Andreas Frutiger | Co-Founder & VP R&D | Leadership |
Tilman Hoss | Co-Founder | Leadership |
Mirko Stange | Managing Director | Leadership |
Klaus-Dieter Langner | Advisor | Board & advisors |
Robert Wicke | Board Member | Board & advisors |
Monique Schiersing | Board Member | Board & advisors |
Christof Fattinger | Advisor | Board & advisors |
Klaus-Peter Stengele | Advisor | Board & advisors |
Matthias Essenpreis | Board Member | Board & advisors |
Marius Rosenberg | Advisor | Board & advisors |
Marco Campanini | Research And Development Specialist | Team |
Surapat Ek-In | Software Engineer | Team |
Complete people profiles for lino Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of lino Biotech
3 dated milestones of lino Biotech across 3 years, from founding to its latest funding, stage changes and deals.
- Founded lino Biotech is founded.
- Funding First funding round.
- Exit Acquired by Miltenyi Biotec.
Web traffic of lino Biotech
The website of lino Biotech (lino-biotech.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lino Biotech
Complete news archive for lino Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about lino Biotech
lino Biotech was founded in 2020.
lino Biotech is headquartered in Zurich, Switzerland.
Focal molography technology was established in 2020 in Zurich, Switzerland, within the biotechnology sector. Photolithography, molecular self-assembly, and optical systems are integrated into a device for label-free assays. Molecular interactions are detected in living cells or unprocessed biological samples. Operations focus on advancing detection methods for research applications.
lino Biotech offers MACS® Matchmaker, Sensor Chips, DNA Adaptors, and Kits.
lino Biotech has 3 investors. Key investors include Roche, Miltenyi Biotec, and High-Tech GrĂĽnderfonds.
lino Biotech operates through Lino Biotech Ag.
Yes. lino Biotech was acquired by Miltenyi Biotec in February 2023.